Maryou Lambros

Institute of Cancer Research — United Kingdom

Medicine · Health Sciences

34h-index5.4kcitations169works22.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(47), Cancer Genomics and Diagnostics(44), HER2/EGFR in Cancer Research(19), Melanoma and MAPK Pathways(19), Monoclonal and Polyclonal Antibodies Research(17)

Publications169 total

Elucidating acquired PARP inhibitor resistance in advanced prostate cancer
Cancer Cell·2024· 22 citedOpen Access
Data from HER3 Is an Actionable Target in Advanced Prostate Cancer
2023Open Access
Figure S5 from HER3 Is an Actionable Target in Advanced Prostate Cancer
2023Open Access
Figure S4 from HER3 Is an Actionable Target in Advanced Prostate Cancer
2023Open Access
Figure S1 from HER3 Is an Actionable Target in Advanced Prostate Cancer
2023Open Access
Figure S3 from HER3 Is an Actionable Target in Advanced Prostate Cancer
2023Open Access
Supplementary Data from HER3 Is an Actionable Target in Advanced Prostate Cancer
2023Open Access
Supplementary Data from HER3 Is an Actionable Target in Advanced Prostate Cancer
2023Open Access
Data from HER3 Is an Actionable Target in Advanced Prostate Cancer
2023Open Access
Supplementary Data from HER3 Is an Actionable Target in Advanced Prostate Cancer
2023Open Access
Figure S4 from HER3 Is an Actionable Target in Advanced Prostate Cancer
2023Open Access
Supplementary Data from HER3 Is an Actionable Target in Advanced Prostate Cancer
2023Open Access
Figure S2 from HER3 Is an Actionable Target in Advanced Prostate Cancer
2023Open Access
Figure S2 from HER3 Is an Actionable Target in Advanced Prostate Cancer
2023Open Access
Figure S1 from HER3 Is an Actionable Target in Advanced Prostate Cancer
2023Open Access
Figure S5 from HER3 Is an Actionable Target in Advanced Prostate Cancer
2023Open Access
Figure S3 from HER3 Is an Actionable Target in Advanced Prostate Cancer
2023Open Access
Press Conference from Functional Viability Profiles of Breast Cancer
2023Open Access
Supplementary Figures 1-8, Tables 1-9 from Functional Viability Profiles of Breast Cancer
2023Open Access
Data from Functional Viability Profiles of Breast Cancer
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Jorge S. Reis‐Filho(28), Johann S. de Bono(18), Alan Mackay(15), Rachael Natrajan(14), Adam Sharp(14), Mateus Crespo(12), Suzanne Carreira(12), George Seed(12), Wei Yuan(11), Diletta Bianchini(11), Christopher J. Lord(11), Pasquale Rescigno(10), Joaquı́n Mateo(10), Ines Figueiredo(10), Semini Sumanasuriya(9), Daniel Nava Rodrigues(9), Alan Ashworth(9), Susana Miranda(9), Cláudia Bertan(9), Ana Ferreira(8)